{"id":30783,"date":"2022-01-01T00:00:00","date_gmt":"2022-01-01T00:00:00","guid":{"rendered":"https:\/\/ibima.eu\/esmo-recommendations-on-the-use-of-circulating-tumour-dna-assays-for-patients-with-cancer-a-report-from-the-esmo-precision-medicine-working-group-2\/"},"modified":"2022-01-01T00:00:00","modified_gmt":"2022-01-01T00:00:00","slug":"esmo-recommendations-on-the-use-of-circulating-tumour-dna-assays-for-patients-with-cancer-a-report-from-the-esmo-precision-medicine-working-group-2","status":"publish","type":"post","link":"https:\/\/ibima.eu\/en\/esmo-recommendations-on-the-use-of-circulating-tumour-dna-assays-for-patients-with-cancer-a-report-from-the-esmo-precision-medicine-working-group-2\/","title":{"rendered":"ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group."},"content":{"rendered":"
Pascual, J; Attard, G; Bidard, F-C; Curigliano, G; De Mattos-Arruda, L; Diehn, M; Italiano, A; Lindberg, J; Merker, J D; Montagut, C; Normanno, N; Pantel, K; Pentheroudakis, G; Popat, S; Reis-Filho, J S; Tie, J; Seoane, J; Tarazona, N; Yoshino, T; Turner, N C – 2022<\/p>","protected":false},"excerpt":{"rendered":"
Pascual, J; Attard, G; Bidard, F-C; Curigliano, G; De Mattos-Arruda, L; Diehn, M; Italiano, A; Lindberg, J; Merker, J D; Montagut, C; Normanno, N; Pantel, K; Pentheroudakis, G; Popat, S; Reis-Filho, J S; Tie, J; Seoane, J; Tarazona, N; Yoshino, T; Turner, N C – 2022<\/p>","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[1568],"tags":[],"acf":[],"yoast_head":"\n